These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4897897)

  • 21. [Determination of antinuclear autoantibodies in progressive systemic sclerosis and its clinical significance].
    Jiang M; Wang HZ; Yuan X
    Zhonghua Nei Ke Za Zhi; 1988 Feb; 27(2):112-4, 136. PubMed ID: 3053068
    [No Abstract]   [Full Text] [Related]  

  • 22. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxins in disease. Autocytotoxins in lupus.
    Terasaki PI; Mottironi VD; Barnett EV
    N Engl J Med; 1970 Oct; 283(14):724-8. PubMed ID: 5311527
    [No Abstract]   [Full Text] [Related]  

  • 24. [The clinical significance of antibodies to SM, RNP and SSR polypeptides detected by immunoblotting technique].
    Xu YH; Chen SL; Ye P
    Zhonghua Nei Ke Za Zhi; 1990 Aug; 29(8):472-5, 510. PubMed ID: 2086016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circumscribed scleroderma with immunologic evidence of systemic lupus erythematosus.
    Mitchell AJ; Rusin LJ; Diaz LA
    Arch Dermatol; 1980 Jan; 116(1):69-73. PubMed ID: 6153258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the problem of immunobiologic relations between lupus erythematosus disseminatus and progressive scleroderma].
    Meyer zum Büschenfelde ; Talke H; Holzmann H
    Arch Klin Exp Dermatol; 1967; 228(4):396-407. PubMed ID: 4171697
    [No Abstract]   [Full Text] [Related]  

  • 29. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects and problems in the definition and standardization of immunofluorescence. I. Present levels of reproducibility and disease specificity of antinuclear antibody tests.
    Beutner EH; Krasny S; Kumar V; Taylor R; Chorzelski TP
    Ann N Y Acad Sci; 1983; 420():28-54. PubMed ID: 6372596
    [No Abstract]   [Full Text] [Related]  

  • 31. [Differentiation of autoantibodies to extractable nuclear antigens using immunoblotting in various collagen diseases].
    Riemekasten G; Hiepe F
    Z Arztl Fortbild (Jena); 1992 Mar; 86(5):217-22. PubMed ID: 1585674
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease.
    Turner-Stokes L; Haslam P; Jones M; Dudeney C; Le Page S; Isenberg D
    Ann Rheum Dis; 1990 Mar; 49(3):160-2. PubMed ID: 2322027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of the indirect immunofluorescence method for the detection of circulating autoantibodies in renal diseases.
    Tchoukanov C; Trenchev P
    Int Urol Nephrol; 1971; 3(1):77-82. PubMed ID: 4949537
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 35. The "true speckled" antinuclear antibody (ANA) pattern: its tumultuous history.
    Burnham TK; Kleinsmith DM
    Semin Arthritis Rheum; 1983 Nov; 13(2):155-9. PubMed ID: 6369542
    [No Abstract]   [Full Text] [Related]  

  • 36. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
    Watanabe S; Miyawaki S
    Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of antibodies directed against double-stranded DNA in the manifestations of systemic lupus erythematosus in childhood.
    Lehman TJ; Hanson V; Singsen BH; Kornreich HK; Bernstein B; King K
    J Pediatr; 1980 Apr; 96(4):657-61. PubMed ID: 6965717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies in childhood connective tissue diseases and in normal children.
    Goel KM; Shanks RA; Whaley K; Mason M; MacSween RN
    Arch Dis Child; 1975 Jun; 50(6):419-23. PubMed ID: 1096832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinuclear antibody determinations in Ro(SSA)-positive, antinuclear antibody--negative lupus and Sjögren's syndrome patients.
    Doré N; Synkowski D; Provost TT
    J Am Acad Dermatol; 1983 May; 8(5):611-5. PubMed ID: 6408145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of cutaneous lupus erythematosus by immunohistochemical methods.
    Pohle EL; Tuffanelli DL
    Arch Dermatol; 1968 May; 97(5):520-6. PubMed ID: 4171670
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.